Free Trial
→ This free guide explains options the way they should be taught (From Base Camp Trading) (Ad)tc pixel Free EOLS Stock Alerts

Evolus (EOLS) Financials

Evolus logo
$7.73 -0.07 (-0.90%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$7.74 +0.01 (+0.19%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Evolus

Annual Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Consolidated Net Income / (Loss)		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Net Income / (Loss) Continuing Operations		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Total Pre-Tax Income 		-12 -47 -105 -163 -47 -74 -62 -50 -51
Total Operating Income		 -12 -46 -99 -153 -44 -65 -49 -34 -33
Total Gross Profit		 0.00 0.00 27 38 56 90 138 182 197
Total Revenue		 0.00 0.00 35 57 100 149 202 266 297
Operating Revenue		 - 0.00 35 57 100 149 202 266 297
Total Cost of Revenue		 0.00 0.00 8.01 18 44 59 65 84 100
Operating Cost of Revenue		 - 0.00 8.01 18 44 59 65 84 100
Total Operating Expenses		 12 46 126 191 101 155 187 217 230
Selling, General & Admin Expense		 4.82 29 114 98 112 142 165 198 221
Research & Development Expense		 6.69 6.49 3.97 1.72 2.06 6.74 15 9.17 9.58
Depreciation Expense		 0.22 0.01 4.13 7.03 5.62 0.77 2.18 2.34 4.35
Restructuring Charge		 - - 0.00 2.96 - - 0.00 0.00 1.44
Other Special Charges / (Income)		 - - 0.00 83 -26 5.76 - 7.18 -6.38
Total Other Income / (Expense), net		 -0.01 -0.66 -6.11 -9.87 -2.36 -8.99 -12 -15 -18
Interest Expense		 0.01 - - 0.00 2.36 9.10 14 19 20
Interest & Investment Income		 0.00 0.20 1.84 0.64 0.00 0.12 0.86 3.26 1.93
Other Income / (Expense), net		 - -0.86 -7.95 -11 0.00 -0.01 0.70 0.13 -0.54
Income Tax Expense		 -7.25 0.07 -15 0.08 0.04 0.10 0.18 0.66 0.68
Basic Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Weighted Average Basic Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 49.77M 56.07M 56.92M 62.02M 64.47M
Diluted Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Weighted Average Diluted Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 49.77M 56.07M 56.92M 62.02M 64.47M
Weighted Average Basic & Diluted Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 55.69M 56.41M 57.94M 63.59M 65.06M

Quarterly Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11 -8.05
Consolidated Net Income / (Loss)		 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11 -8.05
Net Income / (Loss) Continuing Operations		 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11 -8.05
Total Pre-Tax Income 		-12 -13 -11 -19 -6.35 -19 -17 -16 0.52 -10 -8.21
Total Operating Income		 -8.64 -8.92 -7.70 -15 -2.31 -15 -10 -12 4.22 -6.85 -4.54
Total Gross Profit		 39 41 47 42 50 47 45 46 59 49 57
Total Revenue		 61 59 67 61 79 69 69 69 90 73 84
Operating Revenue		 61 59 67 61 79 69 69 69 90 73 84
Total Cost of Revenue		 22 19 20 19 29 22 24 23 31 24 27
Operating Cost of Revenue		 22 19 20 19 29 22 24 23 31 24 27
Total Operating Expenses		 47 49 55 58 53 62 56 57 55 56 62
Selling, General & Admin Expense		 43 45 50 53 50 57 57 53 55 52 57
Research & Development Expense		 6.81 2.08 2.35 2.31 2.43 2.21 1.84 2.05 3.48 2.24 1.89
Depreciation Expense		 -1.58 0.65 0.66 0.32 -1.58 0.82 0.93 1.14 1.45 1.54 1.53
Other Operating Expenses / (Income)		 - - 1.61 - - 2.15 -3.91 -0.11 - -0.01 1.25
Total Other Income / (Expense), net		 -3.09 -4.14 -3.61 -3.56 -4.04 -3.65 -6.88 -4.07 -3.71 -3.57 -3.66
Interest Expense		 4.08 4.70 4.70 4.76 4.57 4.42 7.21 4.09 3.98 3.98 4.17
Interest & Investment Income		 0.29 0.52 1.03 0.93 0.79 0.71 0.48 0.48 0.26 0.29 0.30
Other Income / (Expense), net		 0.69 0.05 0.06 0.27 -0.25 0.06 -0.15 -0.46 0.01 0.12 0.21
Income Tax Expense		 0.11 0.05 0.04 0.13 0.44 0.07 0.05 0.17 0.39 0.26 -0.15
Basic Earnings per Share		 ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16) ($0.12)
Weighted Average Basic Shares Outstanding		 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M 65.93M
Diluted Earnings per Share		 ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16) ($0.12)
Weighted Average Diluted Shares Outstanding		 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M 65.93M
Weighted Average Basic & Diluted Shares Outstanding		 57.94M 62.61M 63.09M 63.32M 63.59M 64.48M 64.69M 64.82M 65.06M 65.85M 66.05M

Annual Cash Flow Statements for Evolus

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -0.19 93 17 -7.33 44 -92 8.92 24 -33
Net Cash From Operating Activities		 -13 -26 -93 -58 -33 -85 -34 -18 -42
Net Cash From Continuing Operating Activities		 -13 -26 -93 -58 -33 -85 -34 -18 -42
Net Income / (Loss) Continuing Operations		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Consolidated Net Income / (Loss)		 -4.48 -47 -90 -163 -47 -74 -62 -50 -52
Depreciation Expense		 0.22 0.01 4.13 7.03 5.62 3.72 5.13 5.30 7.51
Amortization Expense		 - 0.86 1.99 2.92 1.91 1.86 1.85 1.87 2.53
Non-Cash Adjustments To Reconcile Net Income		 -0.41 6.97 9.91 97 -3.87 -2.57 17 25 28
Changes in Operating Assets and Liabilities, net		 -8.55 13 -19 -1.38 9.76 -14 3.37 0.52 -29
Net Cash From Investing Activities		 0.00 -0.01 -23 12 4.03 -2.94 -1.63 -4.82 -8.45
Net Cash From Continuing Investing Activities		 0.00 -0.01 -23 12 4.03 -2.94 -1.63 -4.82 -8.45
Purchase of Property, Plant & Equipment		 0.00 -0.01 -4.57 -3.14 -0.97 -2.94 -1.63 -4.82 -8.45
Net Cash From Financing Activities		 13 119 134 38 73 -4.15 45 47 17
Net Cash From Continuing Financing Activities		 13 119 134 38 73 -4.15 45 47 17
Repayment of Debt		 0.00 -5.00 -3.25 -0.52 -100 -0.50 -0.05 0.00 -2.61
Repurchase of Common Equity		 -1.29 -1.30 -0.20 0.00 -0.21 0.00 0.00 -0.25 0.00
Issuance of Debt		 - 0.00 74 40 72 0.00 50 0.00 25
Issuance of Common Equity		 0.00 124 73 0.00 104 0.00 0.23 56 1.16
Other Financing Activities, net		 14 1.13 -10 -1.13 -3.10 -3.65 -5.54 -8.43 -6.22
Effect of Exchange Rate Changes		 - - - - 0.00 -0.34 -0.09 -0.48 0.25
Cash Interest Paid		 - 0.00 5.17 7.24 0.14 8.00 13 18 15
Cash Income Taxes Paid		 - - 0.00 0.07 0.01 0.08 0.12 0.24 1.22

Quarterly Cash Flow Statements for Evolus

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 24 34 -3.29 -8.64 1.92 -19 -6.16 -18 10 -4.03 -4.62
Net Cash From Operating Activities		 0.81 -11 -6.47 -5.72 4.81 -16 -25 -15 13 -9.95 -3.59
Net Cash From Continuing Operating Activities		 0.81 -11 -6.47 -5.72 4.81 -16 -25 -15 13 -9.95 -3.59
Net Income / (Loss) Continuing Operations		 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11 -8.05
Consolidated Net Income / (Loss)		 -12 -13 -11 -19 -6.79 -19 -17 -16 0.13 -11 -8.05
Depreciation Expense		 1.37 1.41 1.43 1.09 1.37 1.56 1.74 1.95 2.25 2.35 2.34
Amortization Expense		 0.42 0.43 0.44 0.47 0.54 0.56 0.62 0.67 0.68 0.70 0.76
Non-Cash Adjustments To Reconcile Net Income		 8.91 5.27 6.37 6.11 6.96 7.13 5.53 7.60 7.93 5.67 6.31
Changes in Operating Assets and Liabilities, net		 1.94 -4.61 -3.35 5.78 2.73 -5.99 -16 -9.15 1.83 -8.00 -4.94
Net Cash From Investing Activities		 -0.36 -0.80 -1.25 -1.41 -1.36 -1.86 -2.27 -2.16 -2.17 -1.69 -0.50
Net Cash From Continuing Investing Activities		 -0.36 -0.80 -1.25 -1.41 -1.36 -1.86 -2.27 -2.16 -2.17 -1.69 -0.50
Purchase of Property, Plant & Equipment		 -0.36 -0.80 -1.25 -1.41 -1.36 -1.86 -2.27 -2.16 -2.17 -1.69 -0.50
Net Cash From Financing Activities		 24 46 4.48 -1.42 -1.31 -1.63 21 -1.77 0.08 7.62 -0.37
Net Cash From Continuing Financing Activities		 24 46 4.48 -1.42 -1.31 -1.63 21 -1.77 0.08 7.62 -0.37
Repayment of Debt		 -0.01 - - - - 0.00 - - - -0.48 -0.13
Issuance of Common Equity		 -0.20 47 6.51 0.59 -3.38 0.74 0.32 0.02 0.08 0.00 0.31
Other Financing Activities, net		 -1.28 -1.83 -1.78 -2.01 2.06 -2.37 -4.66 -1.79 2.61 -1.90 -0.55
Effect of Exchange Rate Changes		 0.18 -0.13 -0.04 -0.09 -0.22 0.07 0.24 0.38 -0.44 -0.01 -0.17
Cash Interest Paid		 3.80 4.42 4.41 4.47 4.23 4.06 3.73 3.56 3.44 3.25 0.30
Cash Income Taxes Paid		 0.02 0.03 0.14 0.03 0.04 0.05 0.27 0.16 0.74 0.03 0.20

Annual Balance Sheets for Evolus

This table presents Evolus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 152 172 240 209 257 178 189 233 226
Total Current Assets		 73 94 152 128 179 101 112 151 143
Cash & Equivalents		 0.00 93 110 103 146 54 63 87 54
Accounts Receivable		 73 0.00 11 9.68 15 22 31 48 55
Inventories, net		 - 0.00 6.41 3.35 1.76 19 11 12 27
Prepaid Expenses		 0.19 1.18 5.33 4.83 5.08 3.90 5.70 3.35 3.76
Other Current Assets		 - - - 2.19 11 1.68 2.36 1.20 3.67
Plant, Property, & Equipment, net		 0.00 0.00 0.90 1.30 1.37 2.62 2.09 3.22 5.37
Total Noncurrent Assets		 79 78 87 80 77 75 74 78 78
Goodwill		 21 21 21 21 21 21 21 21 21
Intangible Assets		 56 56 60 55 51 49 47 49 48
Other Noncurrent Operating Assets		 2.13 0.22 6.50 3.65 5.48 4.76 6.17 8.04 8.33
Total Liabilities & Shareholders' Equity		 152 172 240 209 257 178 189 233 226
Total Liabilities		 228 87 161 282 176 159 210 227 249
Total Current Liabilities		 213 5.28 24 180 58 47 48 63 75
Accounts Payable		 73 1.56 5.80 9.62 6.09 8.94 4.27 9.24 23
Accrued Expenses		 0.98 3.72 14 9.10 30 25 34 41 36
Other Current Liabilities		 - 0.00 4.68 68 22 13 10 13 16
Total Noncurrent Liabilities		 15 82 137 102 118 113 161 164 174
Long-Term Debt		 0.00 17 91 41 71 72 120 122 146
Noncurrent Deferred & Payable Income Tax Liabilities		 15 15 0.00 0.03 0.04 0.02 0.03 0.01 0.03
Other Noncurrent Operating Liabilities		 0.00 50 45 41 42 41 41 43 28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -76 84 79 -73 82 18 -21 5.52 -23
Total Preferred & Common Equity		 -76 84 79 -73 82 18 -21 5.52 -23
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -76 84 79 -73 82 18 -21 5.52 -23
Common Stock		 0.00 207 293 303 505 516 539 616 638
Retained Earnings		 -76 -123 -213 -376 -423 -497 -559 -609 -661
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 0.01 - 0.00 -0.34 -0.43 -0.91 -0.16

Quarterly Balance Sheets for Evolus

This table presents Evolus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 160 169 168 226 234 230 213 229 219 221 248
Total Current Assets		 84 96 92 150 158 150 132 145 135 139 168
Cash & Equivalents		 31 42 39 97 94 85 68 62 44 50 45
Accounts Receivable		 23 29 30 34 43 45 47 48 50 52 62
Inventories, net		 23 20 18 12 13 15 10 26 33 25 41
Prepaid Expenses		 4.16 4.30 3.66 5.68 5.51 3.40 3.45 4.79 4.60 4.62 4.45
Other Current Assets		 1.59 1.60 1.57 1.84 2.43 2.39 2.89 4.27 3.46 7.50 15
Plant, Property, & Equipment, net		 2.60 2.35 2.13 2.09 2.28 2.31 3.25 3.65 5.13 5.34 5.05
Total Noncurrent Assets		 74 70 74 74 73 77 78 80 79 76 75
Goodwill		 21 21 21 21 21 21 21 21 21 21 21
Intangible Assets		 48 47 47 47 46 47 49 49 49 47 46
Other Noncurrent Operating Assets		 4.42 1.75 6.13 6.02 5.87 9.14 7.82 9.63 9.05 8.44 8.53
Total Liabilities & Shareholders' Equity		 160 169 168 226 234 230 213 229 219 221 248
Total Liabilities		 153 176 187 208 214 224 220 247 248 249 279
Total Current Liabilities		 41 41 49 47 54 61 56 64 67 68 99
Accounts Payable		 10 7.84 12 11 10 14 16 23 23 20 44
Accrued Expenses		 22 24 27 25 33 35 27 28 30 32 38
Other Current Liabilities		 8.38 9.33 10 11 11 12 13 12 13 17 17
Total Noncurrent Liabilities		 113 135 139 161 160 163 164 184 181 181 180
Long-Term Debt		 72 95 95 121 121 121 122 145 146 156 157
Noncurrent Deferred & Payable Income Tax Liabilities		 0.02 0.02 0.02 0.03 0.03 0.03 0.00 0.02 0.00 0.02 0.02
Other Noncurrent Operating Liabilities		 41 40 44 40 39 42 42 38 35 25 23
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 6.95 -6.96 -19 18 19 5.89 -6.60 -19 -29 -29 -31
Total Preferred & Common Equity		 6.95 -6.96 -19 18 19 5.89 -6.60 -19 -29 -29 -31
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 6.95 -6.96 -19 18 19 5.89 -6.60 -19 -29 -29 -31
Common Stock		 519 524 528 591 603 609 623 627 633 643 649
Retained Earnings		 -512 -530 -547 -572 -583 -603 -628 -645 -661 -672 -680
Accumulated Other Comprehensive Income / (Loss)		 -0.42 -0.47 -0.61 -0.56 -0.60 -0.69 -0.84 -0.60 -0.14 -0.28 -0.53

Annual Metrics And Ratios for Evolus

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 27,274,991.00 27,425,230.00 33,749,228.00 55,576,988.00 - - - 64,819,784.00
DEI Adjusted Shares Outstanding		 0.00 27,274,991.00 27,425,230.00 33,749,228.00 55,576,988.00 - - - 64,819,784.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -1.72 -3.28 -4.83 -0.84 - - - -0.80
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 61.89% 76.29% 49.10% 35.98% 31.76% 11.61%
EBITDA Growth		 0.00% -300.88% -118.45% -52.44% 75.99% -62.04% 30.46% 34.74% 14.56%
EBIT Growth		 0.00% -300.86% -127.42% -53.01% 72.85% -47.14% 25.72% 29.37% 3.16%
NOPAT Growth		 0.00% -293.50% -114.44% -54.70% 70.99% -47.12% 24.64% 30.11% 5.08%
Net Income Growth		 0.00% -946.14% -92.11% -81.06% 71.28% -58.97% 17.10% 18.26% -2.42%
EPS Growth		 0.00% -611.11% -66.15% -51.41% 80.54% -41.49% 18.80% 25.00% 1.23%
Operating Cash Flow Growth		 0.00% -94.12% -263.83% 38.03% 42.31% -154.32% 59.95% 47.07% -134.82%
Free Cash Flow Firm Growth		 0.00% 0.00% -550.04% 80.95% -333.75% 10.82% 53.76% 21.55% -90.08%
Invested Capital Growth		 0.00% -87.13% 405.87% -213.27% 114.69% 432.83% 1.03% 8.81% 72.58%
Revenue Q/Q Growth		 0.00% 0.00% 125.64% 2.04% 16.45% 6.44% 9.39% 7.23% 3.97%
EBITDA Q/Q Growth		 0.00% -26.44% -0.35% -163.23% 71.28% 11.22% 6.51% 16.85% 25.23%
EBIT Q/Q Growth		 0.00% -28.81% -2.29% -141.49% 67.64% 10.27% 5.11% 13.55% 16.99%
NOPAT Q/Q Growth		 0.00% -26.44% -0.04% -165.81% 66.96% 10.16% 3.91% 15.52% 16.67%
Net Income Q/Q Growth		 0.00% -56.34% -2.35% -143.93% 66.40% 6.31% 2.12% 9.09% 11.82%
EPS Q/Q Growth		 0.00% -60.00% 0.31% -141.50% 75.07% 13.07% 3.57% 10.00% 13.04%
Operating Cash Flow Q/Q Growth		 0.00% -75.07% -4.38% 19.09% -25.47% 0.32% 21.99% 18.16% 15.95%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% -5.93% 69.74% -84.83% 1.78% 7.21% 18.50% 11.75%
Invested Capital Q/Q Growth		 0.00% 23.33% 21.37% -180.38% -28.42% 3.10% -0.56% -4.72% -5.90%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 0.00% 0.00% 77.05% 67.64% 56.32% 60.41% 68.08% 68.46% 66.33%
EBITDA Margin		 0.00% 0.00% -288.55% -271.71% -37.00% -40.21% -20.56% -10.18% -7.80%
Operating Margin		 0.00% 0.00% -283.31% -270.73% -44.55% -43.96% -24.36% -12.92% -10.99%
EBIT Margin		 0.00% 0.00% -306.08% -289.30% -44.55% -43.97% -24.02% -12.88% -11.17%
Profit (Net Income) Margin		 0.00% 0.00% -257.79% -288.31% -46.96% -50.07% -30.52% -18.94% -17.38%
Tax Burden Percent		 38.19% 100.14% 85.70% 100.05% 100.09% 100.13% 100.29% 101.33% 101.33%
Interest Burden Percent		 100.04% 99.57% 98.28% 99.61% 105.32% 113.74% 126.73% 145.13% 153.50%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% -281.37% 0.00% 0.00% -211.24% -94.05% -62.64% -41.86%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% -245.12% 0.00% 0.00% -110.74% -166.18% -119.84% -87.24%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 171.46% 0.00% 0.00% 62.97% 5,727.38% 727.50% 629.22%
Return on Equity (ROE)		 5.93% -1,060.22% -109.90% -5,016.56% -1,049.79% -148.27% 5,633.33% 664.86% 587.36%
Cash Return on Invested Capital (CROIC)		 0.00% 63.75% -415.35% 0.00% -1,234.84% -348.03% -95.07% -71.08% -95.11%
Operating Return on Assets (OROA)		 0.00% 0.00% -51.86% -72.78% -19.04% -30.01% -26.45% -16.27% -14.48%
Return on Assets (ROA)		 0.00% 0.00% -43.68% -72.53% -20.07% -34.18% -33.62% -23.92% -22.53%
Return on Common Equity (ROCE)		 5.93% -1,060.22% -109.90% -5,016.56% -1,049.79% -148.27% 5,633.33% 664.86% 587.36%
Return on Equity Simple (ROE_SIMPLE)		 5.93% -55.54% -113.31% 223.43% -57.17% -402.25% 298.15% -913.08% 0.00%
Net Operating Profit after Tax (NOPAT)		 -8.21 -32 -69 -107 -31 -46 -34 -24 -23
NOPAT Margin		 0.00% 0.00% -198.32% -189.51% -31.19% -30.77% -17.05% -9.05% -7.69%
Net Nonoperating Expense Percent (NNEP)		 -2.69% 46.67% -36.25% -934.67% -64.67% -100.50% 72.13% 57.20% 45.38%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -50.60% -34.58% -18.96% -18.59%
Cost of Revenue to Revenue		 0.00% 0.00% 22.95% 32.36% 43.68% 39.59% 31.92% 31.54% 33.67%
SG&A Expenses to Revenue		 0.00% 0.00% 325.25% 173.66% 112.44% 95.44% 81.62% 74.37% 74.29%
R&D to Revenue		 0.00% 0.00% 11.38% 3.05% 2.07% 4.54% 7.63% 3.44% 3.22%
Operating Expenses to Revenue		 0.00% 0.00% 360.37% 338.36% 100.87% 104.37% 92.44% 81.39% 77.32%
Earnings before Interest and Taxes (EBIT)		 -12 -47 -107 -164 -44 -65 -49 -34 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -46 -101 -154 -37 -60 -42 -27 -23
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 3.85 4.20 0.00 4.42 22.83 0.00 126.60 0.00
Price to Tangible Book Value (P/TBV)		 0.00 45.71 0.00 0.00 36.03 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 9.56 2.01 3.63 2.84 2.98 2.63 1.45
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.15 30.56 7.19 0.00 41.91 12.08 17.90 18.31 7.57
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 8.46 2.47 2.88 2.96 3.26 2.76 1.76
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 10.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 -1.84 0.20 1.15 -1.84 0.87 3.89 -5.82 22.00 -6.32
Long-Term Debt to Equity		 0.00 0.20 1.15 -0.56 0.87 3.89 -5.82 22.00 -6.32
Financial Leverage		 -1.84 7.06 -0.70 -1.84 -5.45 -0.57 -34.46 -6.07 -7.21
Leverage Ratio		 -2.02 36.66 2.52 69.17 52.32 4.34 -167.57 -27.80 -26.07
Compound Leverage Factor		 -2.02 36.50 2.47 68.90 55.10 4.93 -212.36 -40.34 -40.02
Debt to Total Capital		 219.64% 16.69% 53.51% 219.60% 46.52% 79.53% 120.76% 95.65% 118.79%
Short-Term Debt to Total Capital		 219.64% 0.00% 0.00% 153.20% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 16.69% 53.51% 66.40% 46.52% 79.53% 120.76% 95.65% 118.79%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -119.64% 83.31% 46.49% -119.60% 53.48% 20.47% -20.76% 4.35% -18.79%
Debt to EBITDA		 -12.05 -0.37 -0.91 -0.87 -1.93 -1.20 -2.90 -4.48 -6.31
Net Debt to EBITDA		 -12.05 1.65 0.38 -0.17 2.03 -0.30 -1.38 -1.27 -3.98
Long-Term Debt to EBITDA		 0.00 -0.37 -0.91 -0.26 -1.93 -1.20 -2.90 -4.48 -6.31
Debt to NOPAT		 -16.90 -0.52 -1.32 -1.25 -2.29 -1.57 -3.49 -5.04 -6.39
Net Debt to NOPAT		 -16.90 2.36 0.55 -0.25 2.41 -0.39 -1.67 -1.43 -4.04
Long-Term Debt to NOPAT		 0.00 -0.52 -1.32 -0.38 -2.29 -1.57 -3.49 -5.04 -6.39
Altman Z-Score		 -1.89 0.94 -0.68 -4.89 -0.68 -2.33 -1.79 -0.71 -1.87
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.34 17.88 6.23 0.71 3.10 2.17 2.33 2.40 1.90
Quick Ratio		 0.34 17.66 5.75 0.65 2.79 1.64 1.93 2.14 1.44
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 23 -102 -19 -84 -75 -35 -27 -52
Operating Cash Flow to CapEx		 0.00% -285,188.89% -2,044.73% -1,844.20% -3,442.06% -2,889.15% -2,090.23% -373.19% -500.06%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 -35.74 -8.28 -2.52 -1.46 -2.64
Operating Cash Flow to Interest Expense		 -2,644.40 0.00 0.00 0.00 -14.12 -9.33 -2.46 -0.96 -2.15
Operating Cash Flow Less CapEx to Interest Expense		 -2,644.40 0.00 0.00 0.00 -14.53 -9.66 -2.58 -1.22 -2.58
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.17 0.25 0.43 0.68 1.10 1.26 1.30
Accounts Receivable Turnover		 0.00 0.00 0.00 5.56 8.19 8.01 7.63 6.81 5.81
Inventory Turnover		 0.00 0.00 0.00 3.75 17.02 5.71 4.32 7.25 5.12
Fixed Asset Turnover		 0.00 0.00 0.00 51.42 74.72 74.55 85.94 100.31 69.17
Accounts Payable Turnover		 0.00 0.00 2.18 2.37 5.54 7.83 9.77 12.43 6.14
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 65.66 44.56 45.56 47.84 53.60 62.87
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 97.35 21.45 63.93 84.44 50.33 71.35
Days Payable Outstanding (DPO)		 0.00 0.00 167.47 153.70 65.84 46.60 37.36 29.36 59.45
Cash Conversion Cycle (CCC)		 0.00 0.00 -167.47 9.31 0.17 62.90 94.93 74.58 74.77
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 63 8.13 41 -47 6.84 36 37 40 69
Invested Capital Turnover		 0.00 0.00 1.42 -20.73 -5.02 6.86 5.51 6.92 5.44
Increase / (Decrease) in Invested Capital		 0.00 -55 33 -88 53 30 0.38 3.24 29
Enterprise Value (EV)		 199 248 295 140 287 440 659 734 523
Market Capitalization		 60 325 334 113 362 422 602 699 431
Book Value per Share		 ($4.57) $3.09 $2.90 ($2.16) $1.47 $0.33 ($0.36) $0.09 ($0.36)
Tangible Book Value per Share		 ($9.25) $0.26 ($0.05) ($4.43) $0.18 ($0.91) ($1.56) ($1.02) ($1.42)
Total Capital		 63 101 171 61 153 90 100 127 123
Total Debt		 139 17 91 134 71 72 120 122 146
Total Long-Term Debt		 0.00 17 91 41 71 72 120 122 146
Net Debt		 139 -76 -38 26 -75 18 58 35 92
Capital Expenditures (CapEx)		 0.00 0.01 4.57 3.14 0.97 2.94 1.63 4.82 8.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.24 -4.10 -2.05 -67 -25 0.37 1.29 1.43 14
Debt-free Net Working Capital (DFNWC)		 -1.24 89 128 41 121 54 64 88 68
Net Working Capital (NWC)		 -140 89 128 -53 121 54 64 88 68
Net Nonoperating Expense (NNE)		 -3.73 15 21 56 16 29 27 26 29
Net Nonoperating Obligations (NNO)		 139 -76 -38 26 -75 18 58 35 92
Total Depreciation and Amortization (D&A)		 0.22 0.87 6.12 9.95 7.53 5.58 6.98 7.17 10
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% -5.86% -118.05% -25.20% 0.25% 0.64% 0.54% 4.64%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 365.81% 72.19% 121.53% 36.53% 31.73% 33.19% 22.75%
Net Working Capital to Revenue		 0.00% 0.00% 365.81% -93.10% 121.53% 36.53% 31.73% 33.19% 22.75%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Adjusted Weighted Average Basic Shares Outstanding		 16.53M 27.27M 33.73M 43.73M 49.77M 56.07M 56.92M 62.02M 64.47M
Adjusted Diluted Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) ($0.94) ($1.33) ($1.08) ($0.81) ($0.80)
Adjusted Weighted Average Diluted Shares Outstanding		 16.53M 27.27M 33.73M 43.73M 49.77M 56.07M 56.92M 62.02M 64.47M
Adjusted Basic & Diluted Earnings per Share		 ($0.27) ($1.92) ($3.19) ($4.83) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.53M 24.40M 28.24M 33.74M 55.69M 56.41M 57.94M 63.59M 65.06M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.21 -32 -69 -47 -49 -42 -34 -24 -26
Normalized NOPAT Margin		 0.00% 0.00% -198.32% -82.57% -49.09% -28.06% -17.05% -9.05% -8.86%
Pre Tax Income Margin		 0.00% 0.00% -300.82% -288.18% -46.92% -50.01% -30.44% -18.69% -17.15%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -2,345.20 0.00 0.00 0.00 -18.78 -7.18 -3.51 -1.83 -1.69
NOPAT to Interest Expense		 -1,641.64 0.00 0.00 0.00 -13.15 -5.03 -2.49 -1.29 -1.16
EBIT Less CapEx to Interest Expense		 -2,345.20 0.00 0.00 0.00 -19.19 -7.51 -3.63 -2.09 -2.12
NOPAT Less CapEx to Interest Expense		 -1,641.64 0.00 0.00 0.00 -13.56 -5.35 -2.61 -1.54 -1.59
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -28.71% -2.77% -0.23% 0.00% -0.46% 0.00% 0.00% -0.49% 0.00%

Quarterly Metrics And Ratios for Evolus

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - 63,586,753.00 64,475,589.00 64,685,419.00 64,819,784.00 65,059,990.00 65,854,751.00
DEI Adjusted Shares Outstanding		 - - - - - 63,586,753.00 64,475,589.00 64,685,419.00 64,819,784.00 65,059,990.00 65,854,751.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - -0.30 -0.27 -0.24 0.00 -0.16 -0.12
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 39.76% 42.21% 35.59% 22.12% 29.42% 15.49% 3.70% 12.90% 14.38% 6.74% 21.18%
EBITDA Growth		 31.98% 32.08% 56.75% -16.81% 89.32% -84.41% -38.54% 31.53% 1,190.11% 71.68% 84.56%
EBIT Growth		 24.75% 26.50% 49.40% -13.27% 67.67% -70.27% -35.62% 21.35% 264.78% 55.49% 58.21%
NOPAT Growth		 18.82% 25.90% 49.05% -15.13% 73.20% -70.05% -32.56% 25.68% 165.76% 54.86% 55.50%
Net Income Growth		 10.13% 11.37% 37.43% -13.28% 42.60% -44.11% -51.03% 17.91% 101.91% 43.50% 53.03%
EPS Growth		 16.67% 15.38% 43.75% 0.00% 45.00% -36.36% -50.00% 20.00% 109.09% 46.67% 55.56%
Operating Cash Flow Growth		 109.27% 48.44% 51.39% -519.26% 491.39% -47.26% -283.17% -156.36% 166.78% 36.34% 85.53%
Free Cash Flow Firm Growth		 82.68% 96.52% 74.62% -42.96% 24.25% -1,794.58% -343.26% -149.06% -476.15% -123.46% 26.90%
Invested Capital Growth		 1.03% -11.38% 0.87% 13.56% 8.81% 12.32% 39.78% 74.73% 72.58% 64.54% 23.95%
Revenue Q/Q Growth		 21.95% -2.73% 12.77% -8.70% 29.24% -13.21% 1.26% -0.61% 30.93% -19.01% 14.97%
EBITDA Q/Q Growth		 47.32% -14.50% 17.96% -136.05% 95.18% -1,876.86% 38.37% -16.65% 176.70% -151.35% 66.39%
EBIT Q/Q Growth		 40.82% -11.79% 13.93% -98.95% 83.11% -488.82% 31.45% -15.38% 135.38% -259.05% 35.64%
NOPAT Q/Q Growth		 35.75% -3.32% 13.67% -100.90% 85.04% -555.66% 32.71% -12.63% 113.23% -550.00% 33.66%
Net Income Q/Q Growth		 30.09% -10.80% 13.42% -68.90% 64.57% -178.19% 9.26% 8.20% 100.83% -8,310.77% 24.56%
EPS Q/Q Growth		 33.33% -10.00% 18.18% -66.67% 63.33% -172.73% 10.00% 11.11% 104.17% -1,700.00% 25.00%
Operating Cash Flow Q/Q Growth		 187.99% -1,405.66% 39.05% 11.56% 184.03% -425.12% -58.59% 40.83% 187.44% -177.59% 63.96%
Free Cash Flow Firm Q/Q Growth		 42.10% 87.00% -594.08% -173.74% 69.32% -225.02% -62.39% -53.81% 29.03% -26.06% 46.88%
Invested Capital Q/Q Growth		 -0.56% 14.36% 10.54% -9.66% -4.72% 18.05% 37.57% 12.92% -5.90% 12.55% 3.64%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 63.57% 69.55% 71.49% 70.17% 63.77% 68.09% 65.31% 66.47% 65.66% 66.86% 68.00%
EBITDA Margin		 -10.08% -11.87% -8.64% -22.33% -0.83% -18.95% -11.54% -13.54% 7.93% -5.03% -1.47%
Operating Margin		 -14.16% -15.04% -11.51% -25.33% -2.93% -22.14% -14.71% -16.67% 4.67% -9.36% -5.40%
EBIT Margin		 -13.02% -14.96% -11.42% -24.88% -3.25% -22.06% -14.93% -17.33% 4.68% -9.20% -5.15%
Profit (Net Income) Margin		 -19.40% -22.09% -16.96% -31.38% -8.60% -27.57% -24.70% -22.82% 0.14% -14.59% -9.58%
Tax Burden Percent		 100.90% 100.36% 100.38% 100.70% 106.93% 100.38% 100.31% 101.07% 25.24% 102.46% 98.12%
Interest Burden Percent		 147.65% 147.14% 148.00% 125.24% 247.41% 124.51% 164.94% 130.24% 12.17% 154.85% 189.52%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 74.76% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -54.65% -51.59% -41.24% -111.32% -14.21% -95.48% -51.28% -57.74% 6.42% -31.61% -16.42%
ROIC Less NNEP Spread (ROIC-NNEP)		 -69.98% -72.95% -56.06% -129.34% -25.44% -116.80% -69.30% -68.85% 4.94% -38.94% -21.41%
Return on Net Nonoperating Assets (RNNOA)		 2,411.86% -184.62% -364.83% 888.44% 154.44% -765.51% -11,617.44% 416.72% -35.65% 176.65% 84.40%
Return on Equity (ROE)		 2,357.21% -236.21% -406.07% 777.12% 140.23% -860.99% -11,668.73% 358.98% -29.24% 145.04% 67.97%
Cash Return on Invested Capital (CROIC)		 -95.07% -59.94% -59.29% -84.79% -71.08% -75.26% -87.32% -101.89% -95.11% -76.02% -39.32%
Operating Return on Assets (OROA)		 -14.34% -17.01% -13.45% -31.08% -4.11% -27.65% -17.94% -22.09% 6.07% -12.79% -6.84%
Return on Assets (ROA)		 -21.36% -25.12% -19.99% -39.20% -10.87% -34.56% -29.69% -29.08% 0.19% -20.30% -12.71%
Return on Common Equity (ROCE)		 2,357.21% -236.21% -406.07% 777.12% 140.23% -860.99% -11,668.73% 358.98% -29.24% 145.04% 67.97%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -325.34% -275.52% -941.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -6.04 -6.25 -5.39 -11 -1.62 -11 -7.15 -8.05 1.07 -4.79 -3.18
NOPAT Margin		 -9.91% -10.53% -8.06% -17.73% -2.05% -15.50% -10.30% -11.67% 1.18% -6.55% -3.78%
Net Nonoperating Expense Percent (NNEP)		 15.33% 21.36% 14.83% 18.01% 11.23% 21.32% 18.01% 11.11% 1.47% 7.33% 4.99%
Return On Investment Capital (ROIC_SIMPLE)		 -6.06% - - - -1.28% -9.22% -5.64% -6.88% 0.87% -3.76% -2.53%
Cost of Revenue to Revenue		 36.44% 30.45% 28.51% 29.83% 36.23% 31.91% 34.69% 33.53% 34.34% 33.14% 32.00%
SG&A Expenses to Revenue		 70.59% 76.05% 74.96% 85.96% 63.64% 82.66% 81.68% 76.58% 60.53% 71.07% 67.85%
R&D to Revenue		 11.16% 3.50% 3.51% 3.79% 3.08% 3.23% 2.65% 2.97% 3.85% 3.06% 2.25%
Operating Expenses to Revenue		 77.72% 84.59% 83.00% 95.50% 66.70% 90.23% 80.03% 83.14% 60.99% 76.22% 73.41%
Earnings before Interest and Taxes (EBIT)		 -7.94 -8.88 -7.64 -15 -2.57 -15 -10 -12 4.23 -6.73 -4.33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.15 -7.04 -5.78 -14 -0.66 -13 -8.01 -9.34 7.16 -3.68 -1.24
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 43.98 35.17 173.54 126.60 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 2.98 3.69 2.86 4.12 2.63 2.78 2.14 1.39 1.45 0.89 1.44
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 17.90 19.82 15.18 25.16 18.31 17.31 10.41 6.80 7.57 4.80 7.05
Enterprise Value to Revenue (EV/Rev)		 3.26 3.80 2.98 4.26 2.76 2.97 2.44 1.75 1.76 1.24 1.80
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -5.82 6.54 6.26 20.58 22.00 -18.44 -7.80 -5.07 -6.32 -5.43 -5.07
Long-Term Debt to Equity		 -5.82 6.54 6.26 20.58 22.00 -18.44 -7.80 -5.07 -6.32 -5.43 -5.07
Financial Leverage		 -34.46 2.53 6.51 -6.87 -6.07 6.55 167.65 -6.05 -7.21 -4.54 -3.94
Leverage Ratio		 -167.57 15.22 32.61 -29.50 -27.80 37.13 698.75 -19.62 -26.07 -12.27 -9.62
Compound Leverage Factor		 -247.42 22.39 48.26 -36.94 -68.77 46.23 1,152.50 -25.55 -3.17 -18.99 -18.24
Debt to Total Capital		 120.76% 86.74% 86.23% 95.37% 95.65% 105.73% 114.71% 124.58% 118.79% 122.55% 124.56%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 120.76% 86.74% 86.23% 95.37% 95.65% 105.73% 114.71% 124.58% 118.79% 122.55% 124.56%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -20.76% 13.26% 13.77% 4.63% 4.35% -5.73% -14.71% -24.58% -18.79% -22.55% -24.56%
Debt to EBITDA		 -2.90 -3.16 -3.95 -3.72 -4.48 -3.68 -4.12 -4.70 -6.31 -11.29 -22.11
Net Debt to EBITDA		 -1.38 -0.62 -0.89 -1.11 -1.27 -1.63 -2.37 -3.30 -3.98 -7.69 -15.74
Long-Term Debt to EBITDA		 -2.90 -3.16 -3.95 -3.72 -4.48 -3.68 -4.12 -4.70 -6.31 -11.29 -22.11
Debt to NOPAT		 -3.49 -3.74 -4.46 -4.25 -5.04 -4.28 -4.81 -5.31 -6.39 -9.18 -11.99
Net Debt to NOPAT		 -1.67 -0.73 -1.01 -1.27 -1.43 -1.89 -2.77 -3.73 -4.04 -6.26 -8.54
Long-Term Debt to NOPAT		 -3.49 -3.74 -4.46 -4.25 -5.04 -4.28 -4.81 -5.31 -6.39 -9.18 -11.99
Altman Z-Score		 -1.08 0.19 -0.15 0.40 -0.26 -0.55 -1.02 -1.77 -1.32 -1.97 -1.30
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.33 3.21 2.92 2.47 2.40 2.34 2.27 2.02 1.90 2.04 1.70
Quick Ratio		 1.93 2.80 2.53 2.13 2.14 2.05 1.72 1.41 1.44 1.50 1.09
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -6.42 -0.83 -5.79 -16 -4.86 -16 -26 -39 -28 -35 -19
Operating Cash Flow to CapEx		 225.21% -1,331.87% -515.95% -405.82% 353.01% -839.98% -1,093.56% -679.75% 592.20% -588.53% -717.40%
Free Cash Flow to Firm to Interest Expense		 -1.58 -0.18 -1.23 -3.33 -1.06 -3.58 -3.56 -9.64 -7.04 -8.89 -4.50
Operating Cash Flow to Interest Expense		 0.20 -2.26 -1.38 -1.20 1.05 -3.54 -3.44 -3.58 3.22 -2.50 -0.86
Operating Cash Flow Less CapEx to Interest Expense		 0.11 -2.43 -1.64 -1.50 0.75 -3.96 -3.75 -4.11 2.68 -2.93 -0.98
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.10 1.14 1.18 1.25 1.26 1.25 1.20 1.27 1.30 1.39 1.33
Accounts Receivable Turnover		 7.63 7.62 6.58 6.61 6.81 6.74 6.12 6.01 5.81 6.06 5.75
Inventory Turnover		 4.32 3.86 4.32 4.59 7.25 8.07 4.58 3.99 5.12 5.88 3.13
Fixed Asset Turnover		 85.94 93.83 102.33 111.76 100.31 103.13 93.63 76.78 69.17 70.27 72.76
Accounts Payable Turnover		 9.77 6.31 7.93 5.83 12.43 6.35 5.43 5.18 6.14 5.74 3.11
Days Sales Outstanding (DSO)		 47.84 47.93 55.49 55.20 53.60 54.12 59.66 60.71 62.87 60.27 63.48
Days Inventory Outstanding (DIO)		 84.44 94.56 84.44 79.51 50.33 45.25 79.69 91.40 71.35 62.04 116.76
Days Payable Outstanding (DPO)		 37.36 57.88 46.02 62.59 29.36 57.46 67.20 70.41 59.45 63.61 117.52
Cash Conversion Cycle (CCC)		 94.93 84.61 93.91 72.12 74.58 41.92 72.15 81.70 74.77 58.70 62.72
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 37 42 47 42 40 47 65 73 69 78 81
Invested Capital Turnover		 5.51 4.90 5.12 6.28 6.92 6.16 4.98 4.95 5.44 4.82 4.34
Increase / (Decrease) in Invested Capital		 0.38 -5.41 0.40 5.02 3.24 5.19 19 31 29 31 16
Enterprise Value (EV)		 659 835 707 1,058 734 819 678 499 523 374 569
Market Capitalization		 602 811 679 1,022 699 765 594 397 431 267 457
Book Value per Share		 ($0.36) $0.32 $0.31 $0.09 $0.09 ($0.10) ($0.29) ($0.44) ($0.36) ($0.44) ($0.47)
Tangible Book Value per Share		 ($1.56) ($0.85) ($0.77) ($0.98) ($1.02) ($1.21) ($1.38) ($1.53) ($1.42) ($1.49) ($1.49)
Total Capital		 100 139 140 127 127 115 127 117 123 128 126
Total Debt		 120 121 121 121 122 122 145 146 146 156 157
Total Long-Term Debt		 120 121 121 121 122 122 145 146 146 156 157
Net Debt		 58 24 27 36 35 54 84 102 92 107 112
Capital Expenditures (CapEx)		 0.36 0.80 1.25 1.41 1.36 1.86 2.27 2.16 2.17 1.69 0.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1.29 6.51 10 4.51 1.43 7.59 19 25 14 21 24
Debt-free Net Working Capital (DFNWC)		 64 103 104 90 88 75 81 68 68 71 69
Net Working Capital (NWC)		 64 103 104 90 88 75 81 68 68 71 69
Net Nonoperating Expense (NNE)		 5.79 6.86 5.96 8.34 5.17 8.27 10.00 7.69 0.94 5.88 4.87
Net Nonoperating Obligations (NNO)		 58 24 27 36 35 54 84 102 92 107 112
Total Depreciation and Amortization (D&A)		 1.79 1.83 1.86 1.56 1.91 2.13 2.36 2.62 2.93 3.05 3.09
Debt-free, Cash-free Net Working Capital to Revenue		 0.64% 2.96% 4.36% 1.82% 0.54% 2.76% 7.01% 8.63% 4.64% 6.99% 7.47%
Debt-free Net Working Capital to Revenue		 31.73% 47.09% 43.84% 36.06% 33.19% 27.40% 29.22% 23.85% 22.75% 23.49% 21.74%
Net Working Capital to Revenue		 31.73% 47.09% 43.84% 36.06% 33.19% 27.40% 29.22% 23.85% 22.75% 23.49% 21.74%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16) ($0.12)
Adjusted Weighted Average Basic Shares Outstanding		 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M 65.93M
Adjusted Diluted Earnings per Share		 ($0.20) ($0.22) ($0.18) ($0.30) ($0.11) ($0.30) ($0.27) ($0.24) $0.01 ($0.16) ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding		 56.92M 58.80M 62.72M 63.15M 62.02M 63.70M 64.54M 64.73M 64.47M 65.19M 65.93M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 57.94M 62.61M 63.09M 63.32M 63.59M 64.48M 64.69M 64.82M 65.06M 65.85M 66.05M
Normalized Net Operating Profit after Tax (NOPAT)		 -6.04 -5.14 -4.27 -11 -1.62 -11 -7.15 -7.04 2.95 -4.79 -3.18
Normalized NOPAT Margin		 -9.91% -8.66% -6.38% -17.73% -2.05% -15.50% -10.30% -10.21% 3.27% -6.55% -3.78%
Pre Tax Income Margin		 -19.22% -22.01% -16.90% -31.16% -8.04% -27.47% -24.63% -22.58% 0.57% -14.24% -9.76%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.95 -1.89 -1.63 -3.19 -0.56 -3.42 -1.44 -2.92 1.06 -1.69 -1.04
NOPAT to Interest Expense		 -1.48 -1.33 -1.15 -2.27 -0.35 -2.41 -0.99 -1.97 0.27 -1.21 -0.76
EBIT Less CapEx to Interest Expense		 -2.04 -2.06 -1.89 -3.49 -0.86 -3.85 -1.75 -3.45 0.52 -2.12 -1.16
NOPAT Less CapEx to Interest Expense		 -1.57 -1.50 -1.42 -2.57 -0.65 -2.83 -1.31 -2.49 -0.28 -1.63 -0.88
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% -0.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Evolus’ latest results show improving operating performance, but the company remains unprofitable and highly leveraged. Revenue reached $84.1 million in Q2 2026, up 21.2% from the restated $69.4 million reported in Q2 2025 and well above the $33.9 million generated in Q3 2022. Revenue did decline from $90.3 million in Q4 2025, making the latest quarter a sequential slowdown despite strong year-over-year growth.

Gross profit increased to $57.2 million in Q2 2026 from $45.3 million a year earlier. The gross margin improved to approximately 68.0%, compared with 65.3% in Q2 2025. Selling, general and administrative expense rose only modestly to $57.1 million from $56.7 million, allowing the operating loss to narrow to $4.5 million from $10.2 million. Net loss also improved to $8.1 million, or $0.12 per diluted share, compared with a $17.1 million loss, or $0.27 per share, in Q2 2025.

Despite this progress, Evolus has not established consistent profitability. The company briefly reported a $130,000 profit in Q4 2025 before returning to losses of $10.7 million in Q1 2026 and $8.1 million in Q2 2026. Interest expense remains significant at $4.2 million in the latest quarter, limiting the benefit of improved operating results.

Cash flow trends are better than the income statement suggests, but remain concerning. Operating cash flow was negative $3.6 million in Q2 2026, an improvement from negative $24.8 million in Q2 2025 and negative $10.0 million in Q1 2026. However, Evolus still reduced cash by $4.6 million during the quarter after capital expenditures, financing activity and foreign-exchange effects. Cash and equivalents fell to $45.2 million from $61.7 million one year earlier and $49.8 million at the end of Q1 2026.

  • Strong long-term revenue growth: Quarterly revenue increased from $33.9 million in Q3 2022 to $84.1 million in Q2 2026, reflecting substantial expansion of the business.
  • Improving year-over-year profitability: The Q2 2026 operating loss narrowed by more than half from Q2 2025, while the net loss improved by approximately 53%.
  • Gross margin recovery: Gross margin improved to about 68% in Q2 2026 from roughly 65% in the year-ago quarter, indicating better product economics or sales mix.
  • Lower cash burn: Operating cash outflow fell to $3.6 million in Q2 2026 from $24.8 million in Q2 2025, suggesting improved working-capital management and operating leverage.
  • Stronger liquidity than in 2023: Cash of $45.2 million and current assets of $167.5 million exceed current liabilities of $98.7 million, providing some near-term working-capital support.
  • Revenue momentum is uneven: Q2 revenue grew strongly year over year but declined from the $90.3 million recorded in Q4 2025, so investors should monitor whether growth resumes sequentially.
  • Inventory and receivables are rising: Inventory increased to $40.9 million and accounts receivable to $62.4 million in Q2 2026. This may support future sales, but it also ties up cash and raises execution and collection risks.
  • Persistent net losses: Evolus has reported losses in most of the supplied quarters, and retained earnings reached negative $679.8 million by June 2026.
  • Negative shareholders’ equity: Total liabilities of $278.9 million exceeded total assets of $248.0 million, leaving common equity negative at $30.9 million.
  • High leverage and dilution risk: Long-term debt reached $156.7 million, while the weighted-average diluted share count rose to approximately 65.9 million in Q2 2026 from 62.7 million in Q2 2024. Continued losses could require additional borrowing or equity financing.

Overall, Evolus is showing encouraging revenue growth, better gross margins and a meaningful reduction in cash burn. The more important question for investors is whether these improvements can continue long enough to produce sustained positive operating cash flow and net income. Until that happens, the company’s negative equity, debt burden, declining cash balance and potential need for additional capital remain substantial risks.

10/10/26 04:28 AM ETAI Generated. May Contain Errors.

Evolus Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Evolus' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Over the last 8 years, Evolus' net income changed from -$4.48 million in 2017 to -$51.64 million in 2025, a change of -1,052.7%. Find out what analysts predict for Evolus in the coming months.

Evolus' total operating income in 2025 was -$32.66 million, based on the following breakdown:
  • Total Gross Profit: $197.11 million
  • Total Operating Expenses: $229.77 million

Over the last 8 years, Evolus' total revenue changed from $0.00 in 2017 to $297.18 million in 2025, a change of 29,717,600,000.0%.

In the past 13 quarters, Evolus' cash and equivalents has ranged from $31.46 million in Q1 2023 to $96.96 million in Q1 2024, and is currently $45.17 million as of their latest financial filing in Q2 2026.

Evolus had total debt of $146.10 million at the end of 2025, a 20.2% increase from 2024, and a 5.3% increase since 2017.

Over the last 8 years, Evolus' book value per share changed from -4.57 in 2017 to -0.36 in 2025, a change of 92.2%.


Related Companies

Financial statements for NASDAQ:EOLS last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A simple options setup that cuts through the noise
Ian Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...
TradeWins | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel